Sofia Elizondo is a biotech entrepreneur. She is co-founder and COO of Brightseed, an AI company that discovers bioactive molecules for health based in San Francisco. Brightseed makes proactive, precision health a reality by using pioneering advancements in machine learning to identify bioactive molecules in nature. Brightseed has commercialized novel bioactives in gut health and has a pipeline with nutritional and therapeutic applications across a dozen health areas. It been selected as a Technology Pioneer by the WEF and awarded distinctions by Forbes, Nutritional Outlook, R&D World, Rabobank, FastCompany, Nutra Ingredients and Nutritional Business Journal.

Sofia has helped build multimillion-dollar companies and brands in the consumer goods, pharmaceutical, and technology industries. Before Brightseed, Sofia led the commercialization of plant-based protein products, including the novel mung bean protein isolate. She began her career at the Boston Consulting Group and was also a founding member of the BCG Henderson Institute; the consulting firm's think tank on the future of business innovation. She also served as a Special Advisor to the United Nations supporting their work with the private sector. Her decades of leadership now enable Brightseed's mission to illuminate nature to restore human health.

Sofia's accolades include Top 40 Under 40, San Francisco Business Times; WEF Young Global Leader; 100 Women of Influence, Entrepreneur Magazine; EXTRAORDINARY leaders in Health, Newsweek; Top 100 Female Founders, Inc. Magazine; Women in AI Award, VentureBeat. She has spoken at conferences ranging from nutrition industry with the American Nutrition Association to artificial intelligence and global affairs with the Milken Global Institute and JP Morgan Tech Revolution. Sofia holds a BA in Philosophy, Politics, and Economics from the University of Pennsylvania and an MBA from the Stanford Graduate School of Business.